Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: A case report

被引:10
作者
Agarwal S.K. [1 ]
Kalra V. [1 ]
Dinda A. [2 ]
Gupta S. [1 ]
Dash S.C. [1 ]
Bhowmik D. [1 ]
Tiwari S.C. [1 ]
机构
[1] Department of Nephrology, All India Inst. of Medical Sciences
[2] Department of Pathology, All India Inst. of Medical Sciences
关键词
CMV infection; Fibrosing cholestatic hepatitis; Renal transplant;
D O I
10.1007/s11255-004-6196-9
中图分类号
学科分类号
摘要
Fibrosing cholestatic hepatitis (FCH) is an uncommon complication of renal transplantation. It is usually associated with hepatitis B and C viral infection. It is further rare in renal transplantation in absence of HBV and HCV infection. To the best of our knowledge, only three cases of FCH in renal transplantation, which were both HBV and HCV negative, have been reported to date. Out of these, two cases were diagnosed to have CMV infection and the third was attributed to azathioprin. We are presenting another case of FCH in a renal transplant recipient with CMV infection. © 2004 Kluwer Academic Publishers.
引用
收藏
页码:433 / 435
页数:2
相关论文
共 18 条
  • [1] Davies S.E., Portmann B.C., O'Grady J.G., Et al., Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis, Hepatology, 13, pp. 150-157, (1991)
  • [2] Schluger L.K., Sheiner P.A., Thung S.N., Et al., Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation, Hepatology, 23, pp. 971-976, (1996)
  • [3] Chen C.H., Chen P.J., Chu J.S., Et al., Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation, Gastroenterology, 107, pp. 1514-1518, (1994)
  • [4] Booth J.C., Goldin R.D., Brown J.L., Et al., Fibrosing cholestatic hepatitis in a renal transplant recipient associated with hepatitis B virus precore mutant, J. Hepatol., 22, 4, pp. 500-503, (1995)
  • [5] Lam M.E., Wachs K.A., Somberg P.W.Y., Et al., Fibrosing choletsatic hepatitis in renal transplant recipients, Transplantation, 61, pp. 378-381, (1996)
  • [6] Zylerberberg F., Carnot F., Mamzer M.F., Et al., Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation, Transplantation, 63, pp. 158-160, (1997)
  • [7] Toth C.M., Pascual M., Chung R.T., Et al., Hepatitis C virus associated fibrosing cholestatic hepatitis after renal transplantation: Response to interferon-alpha therapy, Transplantation, 66, 9, pp. 1254-1258, (1998)
  • [8] Munoz de Bustillo E., Benito A., Colina F., Et al., Fibrosing cholestatic hepatitis - Like syndrome in hepatitis B virus - Negative and Hepatitis C Virus - Negative Renal Transplant Recipients, Am. J. Kidney Dis., 38, 3, pp. 640-645, (2001)
  • [9] Duseja A., Nada R., Kalra N., Et al., Fibrosing cholestatic hepatitis like syndrome in a hepatitis B virus and hepatitis C virus negative renal transplant recipient: A case report with autopsy findings, Trop. Gastroenterol., 24, 1, pp. 31-34, (2003)
  • [10] Shan Y.S., Lee P.C., Wang J.R., Et al., Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient, Nephrol. Dial. Transplant, 16, pp. 2420-2422, (2001)